June 20, 2025

Definitive Healthcare Corp. (DH) Stock Analysis: Evaluating the 7.89% Potential Upside in the Healthcare Information Sector

Definitive Healthcare Corp. (NASDAQ: DH) presents an intriguing proposition for investors eyeing the healthcare information services sector. As a provider of a comprehensive software-as-a-service (SaaS) healthcare..

Nutex Health Inc. (NUTX) Investor Outlook: Unpacking a Potential 108.68% Upside

Nutex Health Inc. (NASDAQ: NUTX), a dynamic player in the healthcare sector, is capturing investor attention with a potential upside of 108.68%, according to analyst target..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Closer Look at Its Strong Forward P/E and High RSI

For investors looking to explore opportunities in the healthcare sector, SIGA Technologies Inc. (SIGA) presents an intriguing case. Specializing in the health security market, this commercial-stage..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a 324% Potential Upside with Robust Revenue Growth

MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing attention in the biotechnology sector with its ambitious focus on genetic medicines aimed at addressing serious diseases. As a..

Verastem, Inc. (VSTM) Stock Analysis: A 203% Upside Potential in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM), a pioneering player in the biotechnology industry, is making waves with its ambitious focus on cancer treatment. Headquartered in Needham, Massachusetts, Verastem..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 122% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) is capturing investor attention with its robust potential upside of 122.02%, according to recent analyst ratings. The clinical-stage biopharmaceutical company is..

Cel-Sci Corporation (CVM) Investor Outlook: Examining a Potential 10,381% Upside in the Biotech Space

Cel-Sci Corporation (NYSE American: CVM) is a name that has piqued the interest of speculative investors in the biotech sector, primarily thanks to an eye-catching potential..

Pharvaris N.V. (PHVS) Stock Analysis: A 102.97% Potential Upside You Can’t Ignore

Pharvaris N.V. (PHVS), a pioneering player in the biotechnology sector, has caught the eye of investors with its promising pipeline and substantial growth potential. With a..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a 25.52% Upside Potential Amidst Market Challenges

Fortrea Holdings Inc. (NASDAQ: FTRE), a contract research organization based in Durham, North Carolina, has positioned itself as a key player in the healthcare sector, specifically..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Biotechnology’s Next Big Player with 194.72% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a burgeoning name in the biotechnology sector, is capturing investor interest with its trailblazing approach to autoimmune and inflammatory disease treatments...

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A Promising 229% Upside Potential for Investors

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is capturing investor attention with its significant potential upside, estimated at 229.35%. Specializing..

Akebia Therapeutics, Inc. (AKBA): Unveiling a 107% Potential Upside and Analyst Confidence

Investors looking for promising opportunities in the healthcare sector might find Akebia Therapeutics, Inc. (NASDAQ: AKBA) an intriguing candidate. With a robust market capitalization of $934.98..

Relay Therapeutics, Inc. (RLAY): Analyst Ratings Signal a 313.69% Upside Potential for Investors

Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage biotechnology company based in Cambridge, Massachusetts, is gaining attention in the healthcare sector for its innovative approach to drug..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Unveiling a 115% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is capturing investor attention with its promising upside potential. As a clinical-stage biotechnology company, Amylyx is dedicated to pioneering treatments for..

Septerna, Inc. (SEPN) Stock Analysis: Exploring a Potential 125% Upside in the Biotech Sector

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology firm, is attracting attention in the healthcare sector with its promising pipeline and significant potential upside for investors. Though..

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: A Biotech Play with 245% Potential Upside

Mind Medicine (MindMed) Inc. (MNMD) has recently caught the attention of investors due to its impressive potential upside of 245.56%, making it a compelling option in..

Savara, Inc. (SVRA) Stock Analysis: Strong Buy Ratings Highlight 241% Upside Potential

Investors in the biotechnology sector, particularly those with a focus on rare diseases, may find Savara, Inc. (NASDAQ: SVRA) an intriguing prospect. With a market capitalization..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 78.18% Potential Upside in the Medical Devices Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a burgeoning player in the healthcare sector, operates within the medical devices industry, focusing on innovative solutions for bunion and..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Innovator with Significant Revenue Growth and Strategic Expansion

LifeMD, Inc. (LFMD) is making waves in the healthcare sector with its innovative approach to telehealth services. As a direct-to-patient telehealth company, LifeMD connects consumers with..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: High Growth and Strategic Positioning in the Bioscience Market

Niagen Bioscience, Inc. (NAGE) is gaining attention in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.09 billion, this U.S.-based company..

Search

Funds

June 20, 2025

Search

Funds

June 20, 2025

FTSE 100

Funds